3 ms·
scientist/founders do, see practically all bio-tech startups. exactly the same as in tech - founders reap the big rewards, individual coders less so.
by pinaceae 11y ago
scientist/founders do, see practically all bio-tech startups.
exactly the same as in tech - founders reap the big rewards, individual coders less so.
- mercurial 11y agoHow many of these cancer drugs are made by bio-tech startups, exactly?
- deleted 11y ago[deleted]
- danielweber 11y agoThese don't break it down by "start-up" but: http://pipeline.corante.com/archives/2010/11/04/where_drugs_come_from_the_numbers.php http://pipeline.corante.com/archives/2010/11/04/where_drugs_... 58% from pharmaceutical companies. 18% from biotech companies.. 16% from universities, transferred to biotech. 8% from universities, transferred to pharma. Pharma and biotech companies do develop some drugs themselves, but the majority model is for a start-up to form around a single drug, and if it looks promising a big player buys them up to finish testing and then market it. If the drug looks promising the company is killed. Venture capital is basically doing the job of drug discovery.
- pen2l 11y agoIn my circle of friends at least, PhDs working on various technologies had their names on patents. When big companies bought these patents, they actually received good money. Not retirement money of course, but a few good tens of thousands.